Chairperson: George Zavoico, PhD, Northwest Biotherapeutics 

12:45

Metabolic mechanisms of resistance to cancer vaccination
Lisa Butterfield, PhD, Consultant

1:05 PM

Leveraging Synthetic Antigens to Create Universal Immunotherapies for Solid Tumors
Lex Johnson, PhD, Dispatch Bio 

1:25 PM 

Robert Fenstermaker, MD, MimiVax 

1:45 PM

Introducing Normunity’s Immuno-Smart Targets: Novel Immuno-Relevant Tumor-Specific Targets to Optimize the Safety and Efficacy of Payload-Carrying Biologics
Rachel Humphrey, MD, Normunity